Albany, NY -- (SBWIRE) -- 04/24/2018 -- Vibrio Diagnostics Market: Overview
Vibrio is a genus of anaerobic, non-spore forming, gram-negative bacteria that are curved rod shape. All the species of the vibrio genus are motile pathogens and have flagella with sheaths. Several species of these bacteria are capable of causing various conditionssuch as cholera, gastroenteritis, primary septicemia, cell necrosis and otitis.
The following are some of the diagnostic techniques used for the detection of various diseases associated with vibrio:
Enzyme Immunoassays (EIA)
PCR
Flow Cytometry
Monoclonal Antibodies
Diagnostic Imaging
Immuno-PCR
Fluorescent Immunoassays
Immunoprecipitation
Some of the end-users of vibrio diagnostics techniques are as follows:
Public Health Laboratories
Hospitals
Private and commercial diagnostic labs
Download PDF Brochure of Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2271
Geographically, Asia-Pacific is expected to lead the market due to factors such as poor sanitation, unsafe drinking water and unhygienic living conditions. According to the Centers for Disease Control and Prevention (CDC) disease such as Cholera, caused by Vibrio cholera, is rare in the U.S. and other developed nations. However, the disease is predominantly present in tropical regions including Southeast Asia, Africa and Middle East countries. According to an another report by the CDC, in 2011, globally almost 58 countries registered 589,854 cases of cholera and approximately 7,816 deaths from cholera to WHO in the same year.
Request to View TOC of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2271
The market for vibrio diagnostics market is primarily driven by the initiation of rapid diagnostics tests, rising awareness and increased healthcare expenditure. The market is also expected to witness growth due to other factors such as quick outcome, affordability of the diagnostics kits and devices. Furthermore, development of advance diagnostics techniques such as Polymearse Chain Reaction (PCR) and Enzyme Immunoassays (EIA) are also expected to the drive the market.
Request For Discount On This Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=2271
Some of the major players in this industry segment include Abbott Laboratories, Becton, Dickinson and Company, DiamedixImpex S.A., Eiken Chemical Co. Ltd., Fujirebio Diagnostics Inc., Hologic Inc., Kreatech Holding BV, Lonza Group, Novartis Diagnostics and F. Hoffmann-La Roche Ltd.